Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion

Neurol Neuroimmunol Neuroinflamm. 2020 Apr 2;7(3):e711. doi: 10.1212/NXI.0000000000000711. Print 2020 May.

¹ From the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece. [email protected].
² From the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.

No abstract available

Publication types